As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.
During his more than 30 years at Pfizer, Albert has built a diverse and successful career, holding senior positions across a range of markets and disciplines. When he became CEO in January 2019, Albert accelerated Pfizer’s transformation to become a more science-driven, innovative company – divesting non-science-based businesses, increasing R&D spending, and creating a culture where innovation could thrive.
Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2022, he was named the Genesis Prize Laureate and received the Courage Against Hate Award from the Anti-Defamation League. In 2021, he was named CEO of the Year by CNN Business, included in Insider Magazine’s Most Transformative CEOs list, and inducted into the Crain’s New York Business 2021 Hall of Fame.
Albert is Chair of the Board of Directors for both the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Pfizer Foundation, and Co-Chair of the Board of Directors for the Partnership for New York City.
